Invesco S&P SmallCap Momentum (XSMO)
XSMO price chart
XSMO fund facts
Returns and risk
Cost: expense ratio
On $10,000 invested that is about $36 a year in fund costs, taken out of the fund's assets.
Income: distributions
XSMO top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Invesco Private Prime Fund | 11.81% |
| 2 | Viasat, Inc. | 4.59% |
| 3 | Invesco Private Government Fund | 4.51% |
| 4 | ESCO Technologies Inc. | 2.97% |
| 5 | Protagonist Therapeutics, Inc. | 2.57% |
| 6 | Indivior Pharmaceuticals, Inc. | 2.20% |
| 7 | Mercury Systems, Inc. | 2.17% |
| 8 | StoneX Group Inc. | 2.17% |
| 9 | FormFactor, Inc. | 1.98% |
| 10 | Ligand Pharmaceuticals Inc. | 1.88% |
Similar Small-cap ETFs
SMLF iShares MSCI USA Small-Cap Mul...0.15% fee · +16.2% 1y AVSC Avantis US Small Cap Equity0.25% fee · +24.5% 1y VSS Vanguard FTSE All-World ex-US...0.06% fee · +8.7% 1y IJS iShares S&P Small-Cap 600 Valu...0.18% fee · +20.5% 1y IJT iShares S&P Small-Cap 600 Grow...0.18% fee · +15.3% 1y EWZS iShares MSCI Brazil Small-Cap0.59% fee · +26.4% 1y All small-cap ETFs →XSMO: frequently asked questions
What is XSMO?
XSMO is the Invesco S&P SmallCap Momentum ETF, issued by Invesco, listed on NYSE ARCA. By our rules it is classed as "Small-cap". Its latest SEC filing lists 110 holdings.
What is the expense ratio of XSMO?
XSMO charges 0.36% a year, according to its prospectus filed with the SEC on 27 Aug 2025. On $10,000 that is about $36 a year in fund costs.
Does XSMO pay dividends?
Yes. XSMO paid 0.51 per share over the last 12 months, quarterly, a trailing yield of 0.65% on today's price. The latest ex-dividend date was 21 Sep 2026.
What does XSMO hold?
The largest holdings in the latest SEC filing are Invesco Private Prime Fund (11.8%), Viasat, Inc. (4.6%), Invesco Private Government Fund (4.5%). The top 10 together make up 36.8% of the fund.
How has XSMO performed?
Total return including distributions to 22 Oct 2026: 1 year +9.0%, 3 years +20.6% a year, 5 years +8.1% a year. Past performance does not guarantee future results.
Where the numbers come from
StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.